JAGX News and Press, Jaguar Health Inc.

New patents issued for core rare disease target indications for crofelemer Napo has approximately 200 patents issued and pending Jaguar is supporting investigator-initiated proof-of-concept studies of crofelemer for the rare disease indications of SBS and microvillus inclusion disease (...

2024-06-26 08:42:15 ET More on Jaguar Health Jaguar Health, Inc. (JAGX) Q1 2024 Earnings Call Transcript Jaguar Health slips after update on anti-diarrheal therapy Read the full article on Seeking Alpha For further details see: Jaguar Health regains compl...

Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July 23, 2024 Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific ...

2024-06-12 13:08:58 ET More on Jaguar Health Jaguar Health, Inc. (JAGX) Q1 2024 Earnings Call Transcript Jaguar Health, Inc. (JAGX) Q4 2023 Earnings Call Transcript Jaguar Health extends losses as reverse stock split takes effect Jaguar stock rallies 54% on l...

Investor webcast on or before July 23 will include updates on Jaguar's cancer supportive care portfolio, including participation from Jaguar scientific team, patient advocates, and leading oncology experts on cancer therapy-related diarrhea (CTD) and oral mucositis Cancer patients with diarr...

2024-05-31 10:40:00 ET May 31, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the tech, biotech, automotive, beverage and mining sectors. The newest tech companies are involved...

The drug candidate demonstrates antipsychotic activity and has a mechanism of action distinct from FDA-approved therapies for schizophrenia and other mental conditions that present psychotic symptoms Jaguar to receive percent of milestone payments and increasing royalties upon commercializat...

SAN FRANCISCO, CA / ACCESSWIRE / May 28, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") family company Napo Pharmaceuticals ("Napo") today announced that the results of a third-party, investigator-initiated study of crofelemer, Napo's novel plant-based prescription drug, show that twi...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) rose 12.4% to $0.0886 on volume of 1,366,648,994 shares Ascent Solar Technologies Inc (ASTI) rose 63.4% to $0.2147 on volume of 656,794,712 shares Pineapple Energy Inc. (PEGY) rose 61.4% to $...

2024-05-23 13:02:07 ET More on mid-day movers & stocks. Pineapple Energy Inc. (PEGY) Q1 2024 Earnings Call Transcript Pineapple Energy Inc. (PEGY) Q4 2023 Earnings Call Transcript Pineapple Energy stock trades 40% higher, announces CEO transition Pineappl...